Ferdinando Riccardi
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 62
- Lung Cancer Research Studies 25
- Cancer Treatment and Pharmacology 18
- HER2/EGFR in Cancer Research 13
-
- Lung Cancer Treatments and Mutations 14
- Advanced Breast Cancer Therapies 11
- Co-authors
- Giacomo Cartenì (12 shared papers)Vittorio Gebbia (10 shared papers)Saverio Cinieri (12 shared papers)Luca Boni (9 shared papers)Andrea Ardizzoni (8 shared papers)Francesca Ambrosio (8 shared papers)Marcello Tiseo (6 shared papers)Generoso Uomo (3 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (4 papers)Oncotarget (4 papers)Lung Cancer (3 papers)Cancer (2 papers)
- Partner nations
- ItalyUnited StatesCzechia
In The Last Decade
Ferdinando Riccardi
73 papers receiving 860 citations
Peers
Comparison fields: 5 of 88
- Oncology 602
- Pulmonary and Respiratory Medicine 296
- Epidemiology 283
- Cancer Research 122
- Neurology 108
Countries citing papers authored by Ferdinando Riccardi
This map shows the geographic impact of Ferdinando Riccardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinando Riccardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinando Riccardi more than expected).
Fields of papers citing papers by Ferdinando Riccardi
This network shows the impact of papers produced by Ferdinando Riccardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinando Riccardi. The network helps show where Ferdinando Riccardi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ferdinando Riccardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 132 | |
| 2 | 2010 | 65 | |
| 3 | 2012 | 51 | |
| 4 | 1996 | 40 | |
| 5 | 2022 | 39 | |
| 6 | 2014 | 30 | |
| 7 | 2022 | 27 | |
| 8 | 2010 | 26 | |
| 9 | 2015 | 25 | |
| 10 | 2019 | 24 | |
| 11 | 2013 | 20 | |
| 12 | 2018 | 20 | |
| 13 | 2002 | 20 | |
| 14 | 1997 | 20 | |
| 15 | 2020 | 19 | |
| 16 | 2019 | 18 | |
| 17 | 2014 | 17 | |
| 18 | 2014 | 17 | |
| 19 | 2022 | 16 | |
| 20 | 2000 | 16 |
About Ferdinando Riccardi
Ferdinando Riccardi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Cancer Research, having authored 77 papers that have together received 875 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (25 papers), Neuroendocrine Tumor Research Advances (20 papers), Cancer Treatment and Pharmacology (18 papers), Lung Cancer Treatments and Mutations (14 papers), HER2/EGFR in Cancer Research (13 papers), Advanced Breast Cancer Therapies (11 papers), Breast Cancer Treatment Studies (10 papers) and Cancer therapeutics and mechanisms (9 papers). The work is most often cited by research in Oncology (602 citations), Pulmonary and Respiratory Medicine (296 citations), Epidemiology (283 citations), Cancer Research (122 citations) and Neurology (108 citations). Ferdinando Riccardi has collaborated with scholars based in Italy, United States and Czechia. Frequent co-authors include Giacomo Cartenì, Vittorio Gebbia, Saverio Cinieri, Luca Boni, Andrea Ardizzoni, Francesca Ambrosio, Marcello Tiseo, Generoso Uomo, Claudio Dazzi and Domenico Galetta. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oncotarget, Lung Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.